-
What is the evidence that GLP-1 medications such as Ozempic and Mounjaro might help treat addiction?
Medical Mythbusting Commentary for March 9, 2026 Source:What to know about how GLP-1 medications such as Ozempic and Mounjaro might fight addiction Reference:Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
-
House Calls, #951, December 15, 2024: Eli Lilly Levies Fat Tax on Weight Loss Drug
Dr. Yoni Freedhoff joins me today to discuss the decision by Eli Lilly, manufacturer of Mounjaro, to charge more for patients who are suffering with the affects of obesity. In fact the cost will be double that of people using it for the treatment of their type 2 diabetes. Your Calls and Comments: